Upfront surgery versus definitive radiotherapy: competing risk analyses for cancer-specific and noncancer mortality in oropharyngeal cancer.
Liang PengGuang-Ye ZhanWei SunWei-Ping WenWen-Bin LeiPublished in: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (2024)
Upfront surgery is a superior treatment modality compared with definitive RT in terms of lowering cancer-specific and noncancer mortality in OPC patients, regardless of HPV status. Further prospective clinical trials are needed to confirm our findings.
Keyphrases
- papillary thyroid
- clinical trial
- squamous cell
- minimally invasive
- coronary artery bypass
- cardiovascular events
- early stage
- locally advanced
- ejection fraction
- newly diagnosed
- lymph node metastasis
- cardiovascular disease
- squamous cell carcinoma
- type diabetes
- high grade
- young adults
- rectal cancer
- replacement therapy
- combination therapy